Aimmune Therapeutics, Inc. Insider Trading for May 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aimmune Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aimmune Therapeutics, Inc. for May 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29 2020 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Option Exercise | A | 17.11 | 15,398 | 263,460 | 15,398 | |
| May 29 2020 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Grant | A | 0.00 | 7,840 | 0 | 47,407 | 39.6 K to 47.4 K (+19.81 %) |
| May 29 2020 | AIMT | Aimmune Therapeuti ... | Behar Gregory | Director | Option Exercise | A | 17.11 | 15,398 | 263,460 | 15,398 | |
| May 29 2020 | AIMT | Aimmune Therapeuti ... | Behar Gregory | Director | Grant | A | 0.00 | 7,840 | 0 | 18,032 | 10.2 K to 18 K (+76.92 %) |
| May 29 2020 | AIMT | Aimmune Therapeuti ... | HAUMANN BRETT K | Director | Option Exercise | A | 17.11 | 25,453 | 435,501 | 25,453 | |
| May 29 2020 | AIMT | Aimmune Therapeuti ... | HAUMANN BRETT K | Director | Grant | A | 0.00 | 13,313 | 0 | 19,563 | 6.3 K to 19.6 K (+213.01 %) |
| May 29 2020 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Option Exercise | A | 17.11 | 15,398 | 263,460 | 15,398 | |
| May 29 2020 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Grant | A | 0.00 | 7,840 | 0 | 73,032 | 65.2 K to 73 K (+12.03 %) |
| May 29 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 17.11 | 15,398 | 263,460 | 15,398 | |
| May 29 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | S | 0.00 | 7,840 | 0 | 78,401 | 70.6 K to 78.4 K (+11.11 %) |
| May 29 2020 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Option Exercise | A | 17.11 | 15,398 | 263,460 | 15,398 | |
| May 29 2020 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Grant | A | 0.00 | 7,840 | 0 | 34,692 | 26.9 K to 34.7 K (+29.20 %) |
| May 29 2020 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Option Exercise | A | 17.11 | 15,398 | 263,460 | 15,398 | |
| May 29 2020 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Grant | A | 0.00 | 7,840 | 0 | 18,061 | 10.2 K to 18.1 K (+76.70 %) |
| May 12 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Grant | A | 0.00 | 3,300 | 0 | 126,583 | 123.3 K to 126.6 K (+2.68 %) |
| May 12 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Grant | A | 0.00 | 2,420 | 0 | 45,387 | 43 K to 45.4 K (+5.63 %) |
| May 12 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Grant | A | 0.00 | 2,420 | 0 | 55,378 | 53 K to 55.4 K (+4.57 %) |
| May 12 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Grant | A | 0.00 | 2,420 | 0 | 27,435 | 25 K to 27.4 K (+9.67 %) |
| May 12 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Grant | A | 0.00 | 2,420 | 0 | 29,715 | 27.3 K to 29.7 K (+8.87 %) |